Antipsychotics · Second-Generation (Atypical)
Lumateperone
Brand: Caplyta
Second-generation (atypical) antipsychotic
6 cards
Want adaptive tracking?
Create a free account and every review is tracked with spaced repetition. Cards you struggle with come back sooner, and your weak areas surface automatically.
Create free account →Card Topics
core (2)dosing (1)risk (1)trap (1)interaction (1)
All Cards
1.Lumateperone: unique mechanism distinguishing it from other SGAs.
2.Lumateperone dosing.
3.Lumateperone FDA indications.
4.Most common side effect of lumateperone.
5.Patient on lumateperone 42mg has partial response. Should you increase the dose?
6.Lumateperone CYP interactions.
Want the full clinical reference for this medication?
Read the Lumateperone reference page →